TIFFANY VANGUNDY: Open Payments
NPI 1740630987 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,016 in 150 payments from 21 companies in 2025. Trend: 2023 $2,815 · 2024 $3,656 · 2025 $3,016
Food & beverage: $2,710Education: $306
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $530 |
| Regeneron Healthcare Solutions, Inc. | 14 | $282 |
| E.R. Squibb & Sons, L.L.C. | 12 | $275 |
| ABBVIE INC. | 14 | $231 |
| Incyte Corporation | 11 | $226 |
| PFIZER INC. | 18 | $188 |
| Almirall LLC | 7 | $161 |
| Galderma Laboratories, L.P. | 19 | $149 |
| UCB, Inc. | 7 | $138 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
Products named: DUPIXENT, Sotyktu, OPZELURA, CIBINQO, Bimzelx, COSENTYX, SKYRIZI, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
